Generation of a Sleeping Beauty Transposon-Based Cellular System for Rapid and Sensitive Screening for Compounds and

Marek Widera1, Alexander Wilhelm1,2, Tuna Toptan1

  • 1Institute for Medical Virology, University Hospital Frankfurt am Main, Goethe University, Frankfurt am Main, Germany.

Insights

Researchers developed a new cell model for studying severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infectivity. This high-throughput model enables rapid and sensitive monitoring of SARS-CoV-2, aiding in the discovery of host factors essential for viral replication.

Area of Science:

  • Virology
  • Cell Biology
  • Infectious Diseases

Background:

  • Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes COVID-19, a global health concern.
  • Current methods for monitoring SARS-CoV-2 infectivity in cell culture are time-consuming and labor-intensive.

Purpose of the Study:

  • To develop a robust and versatile cellular infection model for high-throughput and live cell imaging of SARS-CoV-2.
  • To enable rapid and sensitive monitoring of SARS-CoV-2 infection and screening for host factors.

Main Methods:

  • Utilized the Sleeping Beauty transposase system to create a SARS-CoV-2 infection model using A549 lung cells.
  • Introduced ACE2 and TMPRSS2 for constitutive expression (A549-AT) and screened subclones for optimal SARS-CoV-2 susceptibility.
  • Incorporated an inducible fluorescence reporter cassette (eGFP) for doxycycline-inducible expression of host/restriction factors.

Main Results:

  • SARS-CoV-2 infected A549-AT cells showed clear, distinguishable signals (cell roughness, fluorescence, cytopathic effect) approximately 12 hours post-infection.
  • The model demonstrated a good signal-to-noise ratio, facilitating infection monitoring.
  • Sleeping Beauty transposase enabled rapid generation of cell lines with high transfection efficiency and proliferation capacity.

Conclusions:

  • The novel A549-AT cell line serves as an efficient model for SARS-CoV-2 infection studies.
  • This model supports high-throughput screening for antiviral drugs and investigation of host-pathogen interactions.
  • Enables rapid and sensitive monitoring of SARS-CoV-2 and identification of essential host factors for viral replication.

Related Concept Videos